$PWP

Perella Weinberg (NASDAQ:PWP) Delivers Impressive Q2 CY2026

Financial advisory firm Perella Weinberg Partners (NASDAQ: PWP) reported Q2 CY2026 results beating Wall Street’s revenue expectations, but sales were flat year on year at $156.5 million. Its non-GAAP profit of $0.20 per share was significantly above analysts’ consensus estimates. Is now the time to buy Perella Weinberg? Find out by accessing our full research report, it’s free.

Original reporting
Published Jul 31, 2026, 12:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 31, 2026, 12:31 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Perella Weinberg (NASDAQ:PWP) Delivers Impressive Q2 CY2026 — source image
Decision brief

The 30-second read

$PWPBullishMed
01

Why it matters

The quarter’s beat on revenue and non-GAAP EPS, combined with management’s claim of accelerating announced transactions and backlog strength, can support near-term positioning while traders wait for more detailed forward guidance and acquisition-related economics.

02

Market read

Company-specific earnings-style datapoints (revenue beat, non-GAAP EPS beat) plus a fresh acquisition-timing statement create a tradable catalyst for PWP around the reporting window.

03

What to watch

The piece does not quantify guidance, margins, or the financial impact of the Gleacher Shacklock acquisition, which are key for valuation and forward expectations.

Relevance 7/10Novelty 6/10Timing: reported Q2 CY2026 results today (2026-07-31)

Background

Perella Weinberg is an independent financial advisory firm, and the company is also pursuing an acquisition of Gleacher Shacklock expected to close in Q3.

Company-level read

Ticker impact

$PWPBullishMedium confidence
Context

Perella Weinberg reported Q2 CY2026 revenue of $156.5 million, flat YoY, but beating Wall Street estimates by 8.1%.

Expected impact

Near-term bias modestly positive, but magnitude likely limited without new guidance or deal economics beyond the expected Q3 close.

Evidence & confidence

The article provides concrete quarterly figures and a fresh management update on transaction momentum and acquisition timing, which can support sentiment, but it lacks detailed forward guidance or deal terms that typically drive larger repricing.

Market effects

Boutique investment banking and advisory sentiment may improve modestly if transaction activity is broadly strengthening.

No specific regional catalyst beyond US-listed issuer reporting.

Limited, as the disclosure is company-specific with no cross-border deal or macro policy linkage.

Counterpoint

Revenue was flat YoY, and the article’s longer-term demand commentary suggests underlying growth remains muted despite the quarter’s beat.

Key entities

  • Perella Weinberg Partners

    NASDAQ-listed independent financial advisory firm reporting Q2 CY2026 results and discussing transaction momentum and the expected Q3 acquisition close.

  • Gleacher Shacklock

    Acquisition target whose expected Q3 close is referenced by management.

Related articles

$PIPRMedAI 8/10

A Look Back at Investment Banking & Brokerage Stocks’ Q2 Earnings: Piper Sandler (NYSE:PIPR) Vs The Rest Of The Pack

Investment banking & brokerage stocks reported Q2 earnings, with Piper Sandler (PIPR) revenues up 21.2% YoY, beating estimates. Perella Weinberg (PWP) revenues flat but beat estimates, while Houlihan Lokey (HLI) revenues down 15.6% YoY, missing estimates. LPL Financial (LPLA) revenues up 35.2% YoY, beating estimates. Stifel (SF) revenues up 13.2% YoY, beating estimates. Sector revenues beat consensus by 4.5%, with guidance 1.1% below.

$PWPMedAI 8/10

Why Perella Weinberg (PWP) Stock Is Trading Up Today

Perella Weinberg Partners (PWP) shares rose about 17.5% after the firm reported Q2 results. Adjusted EPS was $0.20 versus $0.06 expected and $0.09 a year earlier. Revenue was $156.5 million, flat year over year but 8.1% above expectations, with a 3.9% pre-tax margin. The stock remains below its 52-week high.

$PWPMedAI 8/10

Why is Perella Weinberg Partners stock surging today?

Perella Weinberg Partners (PWP) shares rose 19.3% after the firm reported Q2 results above lowered expectations. Adjusted EPS was $0.20 versus about $0.10 consensus, with revenue at $157 million, up 1% YoY. The article also cites promotions to partner and a $0.07 quarterly dividend, plus supportive sector and Fed backdrop.

$PWPMed

Perella Weinberg Partners (PWP): Results of Operations and Financial Condition

Perella Weinberg Partners (PWP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Perella Weinberg Reports Second Quarter 2026 Results Financial Overview - Second Quarter • Revenues of $157 Million, Up 1% From a Year Ago • GAAP Pre-Tax Income of $6 Million, Adjusted Pre-Tax Income of $27 Million • GAAP Diluted EPS of $0.06, Adjusted EPS of $0.20 F

$UNFIMedAI 8/10

United Natural Foods (UNFI) Calls the Bottom and Guides for Growth Again

United Natural Foods (UNFI) reported Q4 adjusted EPS of $0.69, beating estimates, but revenue of $7.64B missed expectations. The company guided fiscal 2027 sales to $31.2B-$31.8B, up from $31.15B in 2026. Adjusted EBITDA rose 27% to $701M, and free cash flow hit a record $323M. Management expects fiscal 2027 adjusted EPS of $3.00-$3.50. Hedge fund interest declined in Q2.